Tag Archives: Myriad

Dr. Watson, Genomics and the Law

Posted on September 3, 2013 by Warren Woessner

Since the legal tsunami of court decisions affecting many aspects of life sciences – from patents on Round-UpTM Ready soybeans to “companion diagnostics” – has rolled back out to the sea of summer break, I have found time to reflect … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 1 Comment

Patents at the Supreme Court: Update and Fallout

Posted on August 26, 2013 by Warren Woessner

Warren Woessner and Charles R. Macedo will speak on patentable subject matter post-Myriad, Prometheus and CLS in the upcoming AUTM Webinar on September 12.  Warren (Schwegman Lundberg) will present on the patentability of life sciences’ inventions such as diagnostics, drug … Continue reading →

Posted in Patent Eligible Subject Matter, Webinar | Tagged , , , , , , , | Leave a comment

Complimentary Webinar: Patenting DNA

Posted on July 25, 2013 by Warren Woessner

Join Robin Chadwick and me as we untangle the web of rulings in the upcoming webinar “Patenting DNA: Why DNA is Different and What to Do About It.”  The live CLE webinar will be presented on Wednesday, August 7th at … Continue reading →

Posted in Patent Eligible Subject Matter, Webinar | Tagged , , , , , , | Leave a comment

Senator Leahy Urges NIH to Exercise “March-in” Rights on Myriad’s Tests

Posted on July 17, 2013 by Warren Woessner

The Bayh-Dole Act of 1980 grants universities the right to elect to take title in any patent application and patent that was made by their researchers with the support of the Government, e.g., NIH. 35 USC s. 200 et seq. This … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 2 Comments